BioCentury | Dec 22, 2020
Regulation

Dec. 21-23 Regulatory Quick Takes: positive CHMP opinion for Pfizer-BioNTech COVID-19 vaccine; plus Urovant’s approval, a Feb. 9 adcomm for Keytruda in TNBC, NMPA reviewing a subcutaneous PD-L1, and more

...testing.European approval for Orchard’s leukodystrophy therapyOrchard Therapeutics Inc. (NASDAQ:ORTX) and partners Fondazione Telethon and Ospedale San Raffaele...
BioCentury | Aug 1, 2020
Management Tracks

Nabel leaves Moderna’s board to avoid conflict-of-interest concerns; plus changes at Genespire, La Jolla, Editas and more

...Moderna’s COVID-19 vaccine, mRNA-1273. Nabel is also a professor of medicine at Harvard Medical School. San Raffaele...
BioCentury | Jun 19, 2020
Management Tracks

Dubovsky succeeds Fries as Novavax CMO; plus Carl June to head Ziopharm SAB, Dewpoint, FerGene, Cambrex, Adverum, Epsilen and more

...raised €2.3 million ($2.6 million) in seed funding from Sofinnova Partners, also partnered with the San Raffaele...
BioCentury | May 21, 2020
Product Development

May 20 Quick Takes: Filgotinib meets in ulcerative colitis; broader labels for Lynparza, Tecentriq, plus updates from Eiger, eGenesis and more

...SR-Tiget to develop a gene therapy for X-linked hyper-IgM syndrome Sofinnova Partners-backed Genespire Inc. and San Raffaele...
...pembrolizumab (MK-3475, lambrolizumab) Gilead Sciences Inc. Galapagos N.V. Merck & Co. Inc. Eiger BioPharmaceuticals Inc. eGenesis Inc. ICB International Sofinnova Partners Surface Oncology Inc. San Raffaele...
BioCentury | Apr 30, 2020
Finance

April 29 Quick Takes: After ADC approval, Immunomedics raises $420M for rollout; plus Genespire, Vertex, Ocumension and Cadent

...Fund, closed early this year to invest in Italian biotechs. Genespire, which spun out of San Raffaele...
BioCentury | Apr 20, 2020
Finance

French VC Sofinnova expanding start-up ecosystem in Italy with new local fund’s first investments

...partners, Lucia Faccio and Paola Pozzi, have previously led the tech transfer office of Ospedale San Raffaele...
...NASDAQ:ORTX), the first ex vivo gene therapy to gain European approval, was developed by the San Raffaele...
...We keep our head down and we continue to work.” Paul Bonanos, Associate Editor Fondazione Telethon Ospedale San Raffaele Sofinnova...
BioCentury | Mar 21, 2020
Product Development

View from Italy: COVID-19 stalls early-stage companies, could create bargains for international VCs

...for trials being run from hospitals at the outbreak’s epicenter in Northern Italy such as San Raffaele Hospital...
BioCentury | Sep 12, 2019
Financial News

Genenta’s series C marks start of Qianzhan’s European push

...there are still “great science and skills, and fewer investors.” Genenta spun out from the San Raffaele...
BioCentury | May 28, 2019
Company News

May 28 Company Quick Takes: Viela finds China partner for rare CNS disorder mAb; plus Santhera, Juvenescence’s Souvien and more

...as schizophrenia. Orchard gets rights to MPS-I gene therapy Fondazione Telethon (Milan, Italy) and Ospedale San Raffaele...
...Generic) Allergan plc Celgene Corp. Fondazione Telethon Gedeon Richter plc Hansoh Pharmaceutical Group Co. Ltd. Juvenescence Ltd. Newron Pharmaceuticals S.p.A. Orchard Therapeutics plc Ospedale San Raffaele Santhera...
BioCentury | May 28, 2019
Distillery Techniques

Raising lentiviral surface levels of CD47 to improve therapeutic index

...CONTACT: Alessio Cantore, San Raffaele Telethon Institute for Gene Therapy, IRCCS San Raffaele Scientific Institute and Vita-Salute San Raffaele...
...Luigi Naldini, same affiliation as above email: naldini.luigi@hsr.it Sandi Wong Bioverativ Inc. San Raffaele Telethon Institute for Gene Therapy Sanofi Vita-Salute San Raffaele...
Items per page:
1 - 10 of 101
BioCentury | Dec 22, 2020
Regulation

Dec. 21-23 Regulatory Quick Takes: positive CHMP opinion for Pfizer-BioNTech COVID-19 vaccine; plus Urovant’s approval, a Feb. 9 adcomm for Keytruda in TNBC, NMPA reviewing a subcutaneous PD-L1, and more

...testing.European approval for Orchard’s leukodystrophy therapyOrchard Therapeutics Inc. (NASDAQ:ORTX) and partners Fondazione Telethon and Ospedale San Raffaele...
BioCentury | Aug 1, 2020
Management Tracks

Nabel leaves Moderna’s board to avoid conflict-of-interest concerns; plus changes at Genespire, La Jolla, Editas and more

...Moderna’s COVID-19 vaccine, mRNA-1273. Nabel is also a professor of medicine at Harvard Medical School. San Raffaele...
BioCentury | Jun 19, 2020
Management Tracks

Dubovsky succeeds Fries as Novavax CMO; plus Carl June to head Ziopharm SAB, Dewpoint, FerGene, Cambrex, Adverum, Epsilen and more

...raised €2.3 million ($2.6 million) in seed funding from Sofinnova Partners, also partnered with the San Raffaele...
BioCentury | May 21, 2020
Product Development

May 20 Quick Takes: Filgotinib meets in ulcerative colitis; broader labels for Lynparza, Tecentriq, plus updates from Eiger, eGenesis and more

...SR-Tiget to develop a gene therapy for X-linked hyper-IgM syndrome Sofinnova Partners-backed Genespire Inc. and San Raffaele...
...pembrolizumab (MK-3475, lambrolizumab) Gilead Sciences Inc. Galapagos N.V. Merck & Co. Inc. Eiger BioPharmaceuticals Inc. eGenesis Inc. ICB International Sofinnova Partners Surface Oncology Inc. San Raffaele...
BioCentury | Apr 30, 2020
Finance

April 29 Quick Takes: After ADC approval, Immunomedics raises $420M for rollout; plus Genespire, Vertex, Ocumension and Cadent

...Fund, closed early this year to invest in Italian biotechs. Genespire, which spun out of San Raffaele...
BioCentury | Apr 20, 2020
Finance

French VC Sofinnova expanding start-up ecosystem in Italy with new local fund’s first investments

...partners, Lucia Faccio and Paola Pozzi, have previously led the tech transfer office of Ospedale San Raffaele...
...NASDAQ:ORTX), the first ex vivo gene therapy to gain European approval, was developed by the San Raffaele...
...We keep our head down and we continue to work.” Paul Bonanos, Associate Editor Fondazione Telethon Ospedale San Raffaele Sofinnova...
BioCentury | Mar 21, 2020
Product Development

View from Italy: COVID-19 stalls early-stage companies, could create bargains for international VCs

...for trials being run from hospitals at the outbreak’s epicenter in Northern Italy such as San Raffaele Hospital...
BioCentury | Sep 12, 2019
Financial News

Genenta’s series C marks start of Qianzhan’s European push

...there are still “great science and skills, and fewer investors.” Genenta spun out from the San Raffaele...
BioCentury | May 28, 2019
Company News

May 28 Company Quick Takes: Viela finds China partner for rare CNS disorder mAb; plus Santhera, Juvenescence’s Souvien and more

...as schizophrenia. Orchard gets rights to MPS-I gene therapy Fondazione Telethon (Milan, Italy) and Ospedale San Raffaele...
...Generic) Allergan plc Celgene Corp. Fondazione Telethon Gedeon Richter plc Hansoh Pharmaceutical Group Co. Ltd. Juvenescence Ltd. Newron Pharmaceuticals S.p.A. Orchard Therapeutics plc Ospedale San Raffaele Santhera...
BioCentury | May 28, 2019
Distillery Techniques

Raising lentiviral surface levels of CD47 to improve therapeutic index

...CONTACT: Alessio Cantore, San Raffaele Telethon Institute for Gene Therapy, IRCCS San Raffaele Scientific Institute and Vita-Salute San Raffaele...
...Luigi Naldini, same affiliation as above email: naldini.luigi@hsr.it Sandi Wong Bioverativ Inc. San Raffaele Telethon Institute for Gene Therapy Sanofi Vita-Salute San Raffaele...
Items per page:
1 - 10 of 101